NASDAQ:IBB iShares Biotechnology ETF (IBB) Price, Holdings, & News $142.75 -2.04 (-1.41%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$141.80▼$145.6450-Day Range$135.09▼$148.2852-Week Range$111.83▼$150.17Volume1.31 million shsAverage Volume1.54 million shsMarket Capitalization$7.68 billionAssets Under Management$7.57 billionDividend Yield0.28%Net Expense Ratio0.45% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrends Get iShares Biotechnology ETF alerts: Email Address About iShares Biotechnology ETF (NASDAQ:IBB)iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.Read More IBB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IBB ETF News HeadlinesAugust 25, 2024 | fool.com3 ETFs for Growth Investors to Buy and Hold for DecadesAugust 24, 2024 | uk.finance.yahoo.comiShares Nasdaq Biotechnology ETF (IBB)September 7, 2024 | Weiss Ratings (Ad)“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.August 19, 2024 | nasdaq.comSector Update: Health Care Stocks Rise in Late Afternoon TradingAugust 16, 2024 | investing.comDid Retail Stocks and Warren Buffett Save the Market From a Bigger Decline?August 12, 2024 | nasdaq.comSector Update: Health Care Stocks Slipping Late AfternoonAugust 11, 2024 | msn.comDNB MARKETS Upgrades Genmab A (GMAB)August 6, 2024 | hk.finance.yahoo.comIBB Aug 2024 180.000 callSeptember 7, 2024 | Weiss Ratings (Ad)“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.August 5, 2024 | hk.finance.yahoo.comIBB Aug 2024 142.000 putSee More Headlines Receive IBB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssueriShares Fund NameiShares Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBB Inception Date2/5/2001 Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkICE Biotechnology Index (TR) (USD) CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings219 Fund Statistics Assets Under Management$7.57 billion Average Daily Volume$979,536.90 Discount/Premium0.02% Administrator, Advisor and Custodian AdministratorJPMorgan Chase Bank, N.A. AdvisorBlackRock Fund Advisors CustodianJPMorgan Chase Bank, N.A. DistributorBlackRock Investments, LLC Transfer AgentJPMorgan Chase Bank, N.A. TrusteeN/A Lead Market MakerLatour Trading Options OptionableOptionable Options Volume3,846 Put Options1,827 Call Options2,019 Short Interest10,140,000 shs Miscellaneous Outstanding Shares53,800,000Beta0.84 Creation Unit50,000 Creation Fee$614.00 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade iShares Biotechnology ETF ExpensesTypeIBBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.45%0.56%0.55%0.49%0.52%Other Expenses0.00%0.33%0.49%0.41%0.54%Total Expense0.45%0.71%0.71%0.63%0.71%Fee Waiver0.00%-0.45%-0.53%-0.33%-0.58%Net Expense0.45%0.61%0.61%0.56%0.59% iShares Biotechnology ETF (IBB) Holdings & ExposureTop 10 IBB HoldingsRegeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 8.91%Gilead Sciences(NASDAQ:GILD)Holding Weight: 8.72%Amgen(NASDAQ:AMGN)Holding Weight: 7.78%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 7.72%IQVIA(NYSE:IQV)Holding Weight: 4.12%Alnylam Pharmaceuticals(NASDAQ:ALNY)Holding Weight: 3.18%Mettler-Toledo International(NYSE:MTD)Holding Weight: 2.81%Biogen(NASDAQ:BIIB)Holding Weight: 2.78%Moderna(NASDAQ:MRNA)Holding Weight: 2.58%argenx(NASDAQ:ARGX)Holding Weight: 2.46%IBB Sector ExposureIBB Industry ExposureFull Holdings Details Key ExecutivesGeorge G. C. Parker Ph.D.Independent Chairman of the Board of TrusteesMichael Arthur LathamPresident, TrusteeJack GeeChief Financial Officer, TreasurerGeoffrey D. FlynnChief Operating Officer, Executive Vice PresidentBio & Compensation - Amy SchioldagerExecutive Vice PresidentIra P. ShapiroVice President, Chief Legal OfficerMatt TuckerVice PresidentBio & Compensation - Eilleen M. ClavereSecretaryCecilia H. HerbertIndependent TrusteeCharles A. HurtyIndependent TrusteeMore ExecutivesSimilar ETFsVanEck Pharmaceutical ETFNASDAQ:PPHVanEck Biotech ETFNASDAQ:BBHInvesco S&P SmallCap Health Care ETFNASDAQ:PSCHInvesco Dorsey Wright Healthcare Momentum ETFNASDAQ:PTHProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBInstitutional OwnershipSanctuary Advisors LLCBought 64,180 shares on 9/5/2024Ownership: 0.119%Creekside PartnersBought 3,700 shares on 8/30/2024Ownership: 0.007%Aristides Capital LLCBought 66,880 shares on 8/23/2024Ownership: 0.124%Cetera Investment AdvisersBought 341 shares on 8/22/2024Ownership: 0.170%PVG Asset Management CorpBought 3,022 shares on 8/22/2024Ownership: 0.006%View All Institutional Transactions IBB ETF - Frequently Asked Questions How have IBB shares performed this year? iShares Biotechnology ETF's stock was trading at $135.85 at the start of the year. Since then, IBB shares have increased by 5.1% and is now trading at $142.75. View the best growth stocks for 2024 here. When did iShares Biotechnology ETF's stock split? iShares Biotechnology ETF's stock split on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly minted shares were payable to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split. Who are iShares Biotechnology ETF's major shareholders? iShares Biotechnology ETF's top institutional investors include Farallon Capital Management LLC, Susquehanna International Group LLP, LPL Financial LLC (1.14%) and Main Management ETF Advisors LLC (1.08%). How do I buy shares of iShares Biotechnology ETF? Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of iShares Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO) and Micron Technology (MU). This page (NASDAQ:IBB) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
